Home > News > Top Stories > Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions Through AI and Machine Learning Technology

AI

Surgio Health and DARVIS Partner to Deliver Transformative Healthcare Solutions Through AI and Machine Learning Technology

AI and Machine Learning Technology for Healthcare

Surgio Health, a leading healthcare software platform targeting instrument tracking and optimization solutions, has partnered with DARVIS (Data Analytic Real-World Visual Intelligence System), a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. Together, the two are diving into creating innovative instrument tracking and optimization solutions utilizing optical recognition and machine learning technology.

DARVIS is a productivity as a service platform (PaaS) that digitizes objects and processes through AI-powered computer vision technology, enabling it to provide real-time analysis of environments and situations. With the use of computer vision technology, healthcare providers can now easily track objects such as surgical instruments, no matter how small. This allows for tracking and optimization down to the instrument level without the need to individually tag each item. 

Surgio Health is a software as a service platform (SaaS) that provides a fully integrated digital transformation of surgical asset management and optimization for the operating room (OR) and sterile processing department (SPD). With Surgio, facilities can easily locate surgical instruments, ensure proper sterilization steps are taken, coordinate with vendors for loaned and consigned instrument sets, and use interactive analytics to reduce costs and improve productivity.

Using DARVIS's computer vision technology, the two will be able to incorporate the use of AI tracking cameras with Surgio's innovative and in-depth tracking software. With the creation of this partnership, the OR and SPD will be able to manage and optimize their sterilization costs, staffing models, and case readiness.

"DARVIS is thrilled to join forces with Surgio to bring the next age of innovation to healthcare. Our Inventory Tracker platform adds visibility to Surgio's robust existing tracking software. The Inventory Tracker solution can track surgery kits and scopes throughout the equipment's entire lifecycle. This directly translates to immediate boosts in efficiency standards and cost savings." - Jan Schlueter, COO, DARVIS

"Surgio is very excited to partner with DARVIS for the development of transformative Artificial Intelligence through optical recognition and machine learning solutions. Together we will bring actionable data insights that provide real-time visibility and predictability of surgical equipment and staffing optimization to the OR and SPD departments." 

Chris J. Stewart, CEO, Surgio Health

Instrument level tracking becomes even easier with machine learning. Eliminating the need to tag individual instruments makes implementation painless and cost-effective for any hospital system. Surgio and DARVIS will begin by tracking endoscopes, which are often one of the most challenging—and costly—instruments to track and sterilize effectively, with undetectable bioburden frequently remaining in tough-to-clean areas. Through DARVIS's visual tracking system, Surgio can ensure that these scopes are systematically sterilized properly, without additional work being placed on employees.

Together, DARVIS and Surgio want to eliminate patient safety risks and unnecessary processing costs related to sterilization, while simplifying process and workflow for hospitals and their staff. Currently, the two companies plan to release their first partnership solution in 2022.

About Surgio

Surgio Health is a surgical instrument management technology partner for healthcare facilities and medical device manufacturers. Surgio delivers an innovative suite of solutions that drive alignment between OR, sterile processing department (SPD), surgeons, and vendors to lower costs, mitigate risk, and improve efficiencies. Our surgical instrument tracking & optimization, vendor performance management, and manufacturer & distributor asset management solutions follow HIPAA guidelines and are EHR/ERP integrated. Founded in 2015, the company is based in Scottsdale, Arizona. 

About DARVIS

DARVIS (Data Analytic Real-World Visual Intelligence System) is a pioneer in the digitization of hospital logistics, hygiene, and process documentation through AI technology. DARVIS solutions help transform hospitals and healthcare organizations into intelligent autonomous environments that enable healthcare professionals to deliver better and safer patient-centric care. Founded in 2015, the company is based in Nashville, Tennessee. 

Spotlight

More featured news

Spotlight

Related News

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology

GE HealthCare Rolls Out Vscan Air SL Ultrasound Device

GE HealthCare | September 06, 2023

GE HealthCare's latest release is poised to empower healthcare professionals with advanced diagnostic capabilities. Vscan Air SL aims to aid physicians in expediting the identification and treatment of illnesses. This portable, wireless ultrasound imaging device will revolutionize cardiac assessments, seamlessly integrating with diverse ultrasound technologies to enhance GE HealthCare's medical equipment. GE HealthCare has introduced Vscan Air SL, a state-of-the-art medical instrument engineered to enhance the efficiency of healthcare practitioners in diagnosing and treating diverse medical conditions. Due to its portability and wireless functionality, this device excels at conducting cardiac and vascular assessments directly at the patient's bedside. It leverages single-crystal transducer technology, setting a new standard for ultrasound imaging precision. By integrating GE HealthCare's SignalMax and XDclear innovations, Vscan Air SL ensures unparalleled image quality and diagnostic accuracy. This instrument aims to provide remarkable penetration levels, image clarity, and sensitivity, delivering a diagnostic experience of the utmost reliability. Vscan Air SL facilitates the swift acquisition and real-time analysis of high-quality cardiac and vascular images, empowering clinicians with timely insights at the point of care. With its ability to provide immediate, high-quality imaging, Vscan Air SL assists physicians in making well-informed decisions promptly, thereby enhancing patient care. Its intuitive design streamlines healthcare workflows, enabling quicker and more efficient treatment planning for needy patients. Vscan Air SL alleviates the strain on conventional imaging resources by offering on-the-spot diagnostic capabilities, ensuring that medical professionals can deliver care with greater agility and effectiveness. "Having ever more powerful handheld ultrasound is a game changer for patient care," said Guy Lloyd, M.D., FRCP, Consultant Cardiologist at Barts Heart Center, University College London Hospitals and Clinical Director for Cardiovascular Diagnostics and Investigations. GE HealthCare is at the forefront of innovation, working to elevate healthcare delivery standards. The company's intelligent devices, supported by advanced data analytics and harnessing artificial intelligence, profoundly impact millions, facilitating quicker and more informed clinical decisions for healthcare practitioners. By pushing the boundaries of medical technology and knowledge, the company is leaving an indelible mark on the healthcare industry, propelling it towards a future characterized by heightened precision, advanced digitization, and improved well-being for patients worldwide. GE HealthCare is a leader in precision care that harmonizes innovation with patient-focused technologies to enhance healthcare. Its commitment is directed toward providing integrated solutions that optimize hospital efficiency, elevate clinician effectiveness, refine therapeutic precision, and improve patient well-being. It aspires to make contributions to the healthcare sphere that transcend traditional limitations.

Read More

Health Technology, Digital Healthcare

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Business Wire | October 20, 2023

GE HealthCare announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Pre-clinical proof of concept and initial early-stage clinical research suggests that it may impact glucose metabolism in people with diabetes via personalized ultrasound stimulation of nerve pathways. If validated with further clinical evidence, PFUS could represent a non-pharmacologic approach to normalize blood glucose levels in people with type 2 diabetes. The existing technology was developed by a team of scientists at GE HealthCare’s HealthCare Technology and Innovation Center, formerly part of the GE Research Center. said Roland Rott, President and CEO, Ultrasound, GE HealthCare. In an era where diabetes is increasing around the globe, we are enthusiastic about the potential for ultrasound to help people live healthier lives, This collaboration with Novo Nordisk opens a path to evolve ultrasound from a means of screening and diagnosis into therapy, as well. We are eager to validate and further develop this potentially groundbreaking science, as we strive to offer patients alternative treatment options for chronic diseases. [Source – Business Wire] An estimated 540 million adults around the world have diabetes, with type 2 diabetes accounting for more than 90 percent of cases.1 An estimated one in eight individuals will have diabetes in 2045, with significant disease burden in low-and-middle-income countries.1 Given its impact on quality of life and mortality, and with its prevalence increasing at an alarming rate for the past three decades,2 type 2 diabetes is a significant public health burden. Obesity impacts approximately 1 billion people worldwide.3 “We look forward to exploring the potential impact this technology could have on treating people with type 2 diabetes and obesity, as significant unmet needs remain in these diseases in spite of recent advances in care,” said Martin Holst Lange, Executive Vice President and Head of Development at Novo Nordisk. “Although early, the possibilities of using ultrasound for therapeutic purposes are compelling and we welcome our collaboration with GE HealthCare in this truly novel area.” As part of the collaboration, GE HealthCare and Novo Nordisk will contribute their respective expertise in ultrasound medical technology and metabolic disease treatment and management as both parties work together to develop a PFUS solution to improve patient care, building upon the extensive foundational research done to date by the GE HealthCare team. Additional terms of the agreement were not disclosed. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Read More

Health Technology, Digital Healthcare

Best Buy Health and Geisinger Enhance Home Chronic Disease Management

Geisinger | September 13, 2023

Collaborating with Best Buy's Geek Squad ensures faster care, better adherence, and superior outcomes for chronic care patients. In 2021, Geisinger launched ConnectedCare365, enrolling over 1,100 patients in remote monitoring for various chronic conditions via Best Buy Health's Current Health platform. In July 2022, Best Buy Health and Geisinger began a program with Geek Squad Agents to deliver and activate remote care management devices. Best Buy Health and Geisinger have announced their commitment to expand their collaborative efforts to enhance the quality of care for a broader patient population within the Geisinger network. This expansion builds upon their successful delivery of in-home care to patients with chronic conditions through Geek Squad. This initiative currently encompasses 300 Geisinger patients. During their home visits, these agents critically educate patients about the technology integral to their care plan. They offer detailed explanations about the devices, instruct patients on proper usage, and ensure seamless data transmission to the patient's care team. Additionally, agents are available to help with troubleshooting as needed, and they oversee the collection and processing of all devices after a patient leaves the program, following the care team's instructions. The program has achieved a remarkable 50% reduction in the time it takes for a patient to go from admission into the chronic care at-home program to the completion of device setup. This pivotal shift has seen the period shrink from an average of 96 hours to just 48 hours. Furthermore, patients' adherence to their care plans has improved by a commendable 19%, evident in their consistent use of remote technology equipment. Additionally, there has been an 18% decline in reported technical issues, and when replacements were necessary, Geek Squad agents swiftly provided new devices within 24 hours of receiving reports. These exceptional results have garnered positive patient feedback, with a net promoter score of 89 when asked about their experience with Geek Squad's home visits for chronic care program setup. Deborah Di Sanzo, President of Best Buy Health, stated, The results of our program show that when we combine what Best Buy is known for—technology support and expertise—with Geisinger's best-in-class care teams and network of clinics and hospitals, we can make a meaningful difference in the patient and caregiver experience. [Source: Business Wire] Additionally, she emphasized Geisinger's outstanding performance on this initiative. She expressed strong enthusiasm for expanding these capabilities nationwide, in alignment with Best Buy Health's mission to promote accessible at-home care for everyone. Karen Murphy, EVP, Chief Innovation Officer and Founding Director of the Steele Institute for Health Innovation at Geisinger, emphasized the dynamic changes in healthcare. She highlighted the organization's heightened dedication to bringing care closer to patients and members while striving to establish higher care quality standards. The collaboration with Best Buy Health has enabled Geisinger to reshape the healthcare experience, ushering in positive transformations in care delivery and reception. Best Buy aims to enhance lives through technology by providing customers with expert guidance, a diverse product range, and comprehensive in-store and online services. Meanwhile, Geisinger dedicates itself to simplifying the journey to improved health for its extensive community of over one million individuals.

Read More

Health Technology

GE HealthCare Rolls Out Vscan Air SL Ultrasound Device

GE HealthCare | September 06, 2023

GE HealthCare's latest release is poised to empower healthcare professionals with advanced diagnostic capabilities. Vscan Air SL aims to aid physicians in expediting the identification and treatment of illnesses. This portable, wireless ultrasound imaging device will revolutionize cardiac assessments, seamlessly integrating with diverse ultrasound technologies to enhance GE HealthCare's medical equipment. GE HealthCare has introduced Vscan Air SL, a state-of-the-art medical instrument engineered to enhance the efficiency of healthcare practitioners in diagnosing and treating diverse medical conditions. Due to its portability and wireless functionality, this device excels at conducting cardiac and vascular assessments directly at the patient's bedside. It leverages single-crystal transducer technology, setting a new standard for ultrasound imaging precision. By integrating GE HealthCare's SignalMax and XDclear innovations, Vscan Air SL ensures unparalleled image quality and diagnostic accuracy. This instrument aims to provide remarkable penetration levels, image clarity, and sensitivity, delivering a diagnostic experience of the utmost reliability. Vscan Air SL facilitates the swift acquisition and real-time analysis of high-quality cardiac and vascular images, empowering clinicians with timely insights at the point of care. With its ability to provide immediate, high-quality imaging, Vscan Air SL assists physicians in making well-informed decisions promptly, thereby enhancing patient care. Its intuitive design streamlines healthcare workflows, enabling quicker and more efficient treatment planning for needy patients. Vscan Air SL alleviates the strain on conventional imaging resources by offering on-the-spot diagnostic capabilities, ensuring that medical professionals can deliver care with greater agility and effectiveness. "Having ever more powerful handheld ultrasound is a game changer for patient care," said Guy Lloyd, M.D., FRCP, Consultant Cardiologist at Barts Heart Center, University College London Hospitals and Clinical Director for Cardiovascular Diagnostics and Investigations. GE HealthCare is at the forefront of innovation, working to elevate healthcare delivery standards. The company's intelligent devices, supported by advanced data analytics and harnessing artificial intelligence, profoundly impact millions, facilitating quicker and more informed clinical decisions for healthcare practitioners. By pushing the boundaries of medical technology and knowledge, the company is leaving an indelible mark on the healthcare industry, propelling it towards a future characterized by heightened precision, advanced digitization, and improved well-being for patients worldwide. GE HealthCare is a leader in precision care that harmonizes innovation with patient-focused technologies to enhance healthcare. Its commitment is directed toward providing integrated solutions that optimize hospital efficiency, elevate clinician effectiveness, refine therapeutic precision, and improve patient well-being. It aspires to make contributions to the healthcare sphere that transcend traditional limitations.

Read More

Health Technology, Digital Healthcare

GE HealthCare and Novo Nordisk to Collaborate to Advance Novel Non-Invasive Treatment for Type 2 Diabetes and Obesity with Ultrasound

Business Wire | October 20, 2023

GE HealthCare announced a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity. PFUS is a non-invasive type of bioelectronic medicine that uses ultrasound to activate the nervous system to stimulate a response that may be able to treat disease. Pre-clinical proof of concept and initial early-stage clinical research suggests that it may impact glucose metabolism in people with diabetes via personalized ultrasound stimulation of nerve pathways. If validated with further clinical evidence, PFUS could represent a non-pharmacologic approach to normalize blood glucose levels in people with type 2 diabetes. The existing technology was developed by a team of scientists at GE HealthCare’s HealthCare Technology and Innovation Center, formerly part of the GE Research Center. said Roland Rott, President and CEO, Ultrasound, GE HealthCare. In an era where diabetes is increasing around the globe, we are enthusiastic about the potential for ultrasound to help people live healthier lives, This collaboration with Novo Nordisk opens a path to evolve ultrasound from a means of screening and diagnosis into therapy, as well. We are eager to validate and further develop this potentially groundbreaking science, as we strive to offer patients alternative treatment options for chronic diseases. [Source – Business Wire] An estimated 540 million adults around the world have diabetes, with type 2 diabetes accounting for more than 90 percent of cases.1 An estimated one in eight individuals will have diabetes in 2045, with significant disease burden in low-and-middle-income countries.1 Given its impact on quality of life and mortality, and with its prevalence increasing at an alarming rate for the past three decades,2 type 2 diabetes is a significant public health burden. Obesity impacts approximately 1 billion people worldwide.3 “We look forward to exploring the potential impact this technology could have on treating people with type 2 diabetes and obesity, as significant unmet needs remain in these diseases in spite of recent advances in care,” said Martin Holst Lange, Executive Vice President and Head of Development at Novo Nordisk. “Although early, the possibilities of using ultrasound for therapeutic purposes are compelling and we welcome our collaboration with GE HealthCare in this truly novel area.” As part of the collaboration, GE HealthCare and Novo Nordisk will contribute their respective expertise in ultrasound medical technology and metabolic disease treatment and management as both parties work together to develop a PFUS solution to improve patient care, building upon the extensive foundational research done to date by the GE HealthCare team. Additional terms of the agreement were not disclosed. About GE HealthCare Technologies Inc. GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 100 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are an $18.3 billion business with 50,000 employees working to create a world where healthcare has no limits.

Read More

More featured news